ArticleScientific reports2025
A comprehensive metabolomic study of three Egyptian Salsola species revealed their potential anti-inflammatory activity.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Metabolomic Profiling of Medicinal Plant-Based Soft Porridge and Evaluation of Cytotoxicity.Metabolites · 2026Article
- The Metabolic Diversity of DifferentPlants (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Salsola plants are halophytic crops that are distributed worldwide, with more than 100 species figured out in Asia, the Mediterranean region and North Africa. Different Salsola species were reported to exert marked anti-inflammatory activities, whereas the potential anti-inflammatory activities of the three species, S. tetrandra, S. tetragona and S. vermiculata, have not been evaluated. This study provides a comprehensive metabolic study of the shoots and roots of those three species to identify potential anti-inflammatory candidates. An ultra-high performance liquid chromatography mass-mass spectrometry (UHPLC MS/MS) method in conjunction with multivariate analysis principles was utilized in an attempt to decipher their bio-active metabolites and their relevant anti-inflammatory activities. Eighty metabolites were identified in the tested extracts, where nitrogenous compounds and phenolics were highly detected in S. tetragona samples, meanwhile, saponins and phenolic acids were highly dominant in S. tetrendra sample and S. vermiculata samples have a similar chemical profile as S. tetrandra. Concerning the anti-inflammatory activity of the tested extracts, the safety margin of all the tested extracts was higher than that of the standard drug piroxicam. The shoots of the three species demonstrated more potent anti-inflammatory activities compared to the roots. The shoot extract of S. tetrandra was the most biologically active fraction. The obtained results revealed the shoots of the three Salosla species to be promising anti-inflammatory drug candidates of high safety and efficacy that could be used in the pharmaceutical industry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.